CRISPR Therapeutics AG (CRSP)

Last Closing Price: 56.26 (2025-09-12)

Income after Taxes (Annual)

Income after Taxes: Earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.

CRISPR Therapeutics AG (CRSP) had Income after Taxes of $-366.25M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$37.31M
$-366.25M
--
$37.31M
$503.88M
$-466.57M
$103.90M
$-362.67M
$-362.67M
Income after Taxes
$-366.25M
$-366.25M
$-366.25M
$-366.25M
$-466.57M
$-447.31M
84.36M
84.36M
$-4.34
$-4.34
Balance Sheet Financials
$1.94B
$134.09M
$304.90M
$2.24B
$87.78M
--
$222.17M
$309.95M
$1.93B
$1.93B
$1.93B
85.74M
Cash Flow Statement Financials
$-142.77M
$-280.48M
$331.98M
$401.07M
$309.78M
$-91.29M
$86.57M
--
--
Fundamental Metrics & Ratios
22.07
--
--
--
--
100.00%
-1250.38%
-1250.38%
-1198.77%
-971.93%
-981.54%
$-144.68M
--
--
--
0.02
--
1.49
244.55
-18.96%
-18.96%
-16.34%
-18.96%
$22.53
$-1.72
$-1.69